Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Advisory Committee Vacancies, Qualifications, and Experience

Advisory Committee Vacancies, Qualifications, and Experience

                        Blood, Vaccines, Biological Products Committee Vacancies
          Drug Products Committee Vacancies
          Food Advisory Committee Vacancies
          Medical Devices and Radiation-Emitting Products Committee Vacancies
          Science Board to the FDA, Risk Communication, and Pediatrics Vacancies
          Toxicological Research Vacancies
          Tobacco Advisory Committee Vacancies Home
          Advisory Committees
          About Advisory Committees
          Advisory Committee Membership
          Advisory Committee Vacancies, Qualifications, and Experience
          Drug Products Committee VacanciesAdvisory Committee Vacancies, Qualifications, and Experience Drug Products Committee Vacancies
  
  					Human Drugs
	
    Share
    Post
    Linkedin

    Email
    PrintCenter for Drug Evaluation and Research (CDER)

Committee
			Function
			Qualifications
			Current
			VacanciesGenetic Metabolic Diseases Advisory Committee
			Reviews and evaluates data on the safety and effectiveness of marketed and investigational human drug and biologic products for use in the treatment of genetic metabolic diseases and makes appropriate recommendations to the Commissioner of Food and Drugs.
			Knowledgeable in the fields of medical genetics, manifestations of inborn errors of metabolism, small population trial design, translational science, pediatrics, epidemiology, or statistics and related specialties.
			9Anesthetic and Analgesic Drugs Advisory Committee
			Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in anesthesiology and surgery.
			Knowledgeable in the fields of anesthesiology, surgery, epidemiology or statistics, and related specialties.
			1Antimicrobial Drugs Advisory Committee formerly called the Anti-Infective Drugs Advisory Committee
			Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of infectious diseases and disorders.
			Knowledgeable in the fields of infectious disease, internal medicine, microbiology, pediatrics, epidemiology or statistics, and related specialties.
			1Antiviral Drugs Advisory Committee

			**Committee Terminated 2/15/2015**
			**Committee Terminated 2/15/2015**Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of acquired immune deficiency syndrome, human immunodeficiency virus related illnesses, and other viral, fungal and mycobacterial infections.
			**Committee Terminated 2/15/2015**Knowledgeable in the fields of clinical pharmacology, internal medicine, infectious diseases, microbiology, virology, psychiatry, statistics, epidemiology, ophthalmology, immunology, pediatrics, hematology, and related specialties.
			**Committee Terminated 2/15/2015**Arthritis Drugs Advisory Committee
			Reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of arthritis, rheumatism, and related diseases.
			Knowledgeable in the fields of arthritis, rheumatology, orthopedics, epidemiology or statistics, analgesics, and related specialties.
			0Bone, Reproductive & Urologic Drugs Advisory Committee formerly called the Advisory Committee for Reproductive Health Drugs
			Reviews and evaluates data on the safety and effectiveness of marketed and investigational human drugs for use in the practice of obstetrics, gynecology, and related specialties.
			Knowledgeable in the fields of obstetrics, gynecology, endocrinology, pediatrics, epidemiology or statistics and related specialties.
			4Cardiovascular and Renal Drugs Advisory Committee
			Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of cardiovascular and renal disorders.
			Knowledgeable in the fields of cardiology, hypertension, arrhythmia, angina, congestive heart failure, diuresis, and biostatistics.
			0Dermatologic and Ophthalmic Drugs Advisory Committee
			Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of dermatologic and ophthalmic disorders.
			Knowledgeable in the fields of dermatology, ophthalmology, internal medicine, pathology, immunology, epidemiology or statistics, and other related professions.
			0Drug Safety and Risk Management Advisory Committee
			Risk management, risk communication, and quantitative evaluation of spontaneous reports for drugs for human use and for any other product for which the FDA has regulatory responsibility. Scientific and medical evaluation of all information gathered by the DHHS and the Department of Justice with regard to safety, efficacy, and abuse potential of drugs or other substances, and recommends actions to be taken by the DHHS with regard to the marketing, investigation, and control of such drugs or other substances.
			Knowledgeable in risk communication, risk management, drug safety, medical, behavioral, and biological sciences as they apply to risk management, and drug abuse.
			1Endocrinologic and Metabolic Drugs Advisory Committee
			Reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of endocrine and metabolic disorders.
			Knowledgeable in the fields of endocrinology, metabolism, epidemiology or statistics, and related specialties.
			0Gastrointestinal Drugs Advisory Committee
			Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of gastrointestinal diseases.
			Knowledgeable in the fields of gastroenterology, endocrinology, surgery, clinical pharmacology, physiology, pathology, liver function, motility, esophagitis, and statistics.
			1Medical Imaging Drugs Advisory Committee
			Reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in diagnostic and therapeutic procedures using radioactive pharmaceuticals and contrast media used in diagnostic radiology.
			Knowledgeable in the fields of nuclear medicine, radiology, epidemiology, statistics and related specialties.
			1Nonprescription Drugs Advisory Committee
			Review and evaluate available data concerning the safety and effectiveness of over-the-counter (nonprescription) human drug products, or any other FDA-regulated product, for use in the treatment of a broad spectrum of human symptoms and diseases and advise the Commissioner either on the promulgation of monographs establishing conditions under which these drugs are generally recognized as safe and effective and not misbranded or on the approval of new drug applications for such drugs. The Committee will serve as a forum for the exchange of views regarding the prescription and nonprescription status, including switches from one status to another, of these various drug products and combinations thereof. The Committee may also conduct peer review of agency sponsored intramural and extramural scientific biomedical programs in support of FDA's mission and regulatory responsibilities.
			Knowledgeable in the fields of internal medicine, family practice, clinical toxicology, clinical pharmacology, pharmacy, dentistry, and related specialties.
			1Oncologic Drugs Advisory Committee
			Reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of cancer.
			Knowledgeable in the fields of general oncology, pediatric oncology, hematologic oncology, immunologic oncology, biostatistics, and other related professions.
			3Peripheral and Central Nervous System Drugs
			Reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of neurologic diseases.
			Knowledgeable in the fields of neurology, neuropharmacology, neuropathology, otolaryngology, epidemiology or statistics, and related specialties.
			0Pharmacy Compounding Advisory Committee
			Provides advice on scientific, technical, and medical issues concerning drug compounding by pharmacists and licensed practitioners.
			Knowledgeable in the fields of pharmaceutical compounding, pharmaceutical manufacturing, pharmacy, medicine and other related specialties.
			1Pharmaceutical Science and Clinical Pharmacology Advisory Committee
			Provide advice on scientific and technical issues concerning the safety, and effectiveness of human generic drug products for use in the treatment of a broad spectrum of human diseases, and as required, any other product for which the FDA has regulatory responsibility. The committee may also review Agency sponsored intramural and extramural biomedical research programs in support of FDA's generic drug regulatory responsibilities.
			Knowledgeable in the fields of pharmaceutical manufacturing, clinical pharmacology, pharmacokinetics, bioavailability and bioequivalence research, the design and evaluation of clinical trials, laboratory analytical techniques, pharmaceutical chemistry, physiochemistry, biochemistry, biostatistics and related biomedical and pharmacological specialties.
			3Psychopharmacologic Drugs Advisory Committee
			Reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the practice of psychiatry and related fields.
			Knowledgeable in the fields of psychopharmacology, psychiatry, epidemiology or statistics, and related specialties.
			0Pulmonary-Allergy Drugs Advisory Committee
			Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of pulmonary disease and diseases with allergic and/or immunologic mechanisms.
			Knowledgeable in the fields of pulmonary medicine, allergy, clinical immunology, and epidemiology or statistics.
			0

Related Materials

Advisory Committee Vacancies, Qualifications, and Experience
	Listing by Center of Current Advisory Committee Vacancies
	Advisory Committees
	FDA Advisory Committee Home Page
	Human Drug Advisory Committees
	More information about Human Drug Advisory Committees
	Applying for Membership on FDA Advisory Committees
	How to submit information for consideration as an Advisory Committee member

                                                                                  Content current as of:
      12/13/2023
              
              
Regulated Product(s)
		 DrugsAdvisory Committee Vacancies, Qualifications, and Experience

          
                        Blood, Vaccines, Biological Products Committee Vacancies
          Drug Products Committee Vacancies
          Food Advisory Committee Vacancies
          Medical Devices and Radiation-Emitting Products Committee Vacancies
          Science Board to the FDA, Risk Communication, and Pediatrics Vacancies
          Toxicological Research Vacancies
          Tobacco Advisory Committee Vacancies
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop